NCT05292664 2026-03-12
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Dana-Farber Cancer Institute
Phase 1 Recruiting
Dana-Farber Cancer Institute
Novartis
Regeneron Pharmaceuticals
Thomas Jefferson University
Children's Hospital of Philadelphia